Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Connor

Showing results (571-580 of 804) with videos related to

Pageof 81
Sort By:
Transplantation and Cellular Therapy|April 4, 2023
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationJuliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, et al.
Blood Advances|October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysisMehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2025
Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving ChemoimmunotherapyP Connor Johnson, Jeremy S Abramson, Ann S LaCasce, et al.
American Journal of Hematology|May 21, 2024
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysisAseel Alsouqi, Gulrayz Ahmed, Juntian Wang, et al.
Blood Neoplasia|June 2, 2025
Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational studyPriyanka Pullarkat, Matthew Lei, Robert Redd, et al.
Haematologica|April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemiaMatthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Neurogastroenterology and Motility|May 11, 2026
A Clinical Practice Update for the Management of Patients With Disorders of Gut-Brain Interaction and Altered Food Intake BehaviorAyesha Shah, Nicholas J Talley, Simon R Knowles, et al.
Transplantation and Cellular Therapy|November 6, 2022
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid MalignanciesMatthew P Connor, Alison W Loren, Elizabeth O Hexner, et al.
Journal of Geriatric Oncology|June 17, 2023
Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemiaP Connor Johnson, Jennifer A Woyach, Angela Ulrich, et al.
Pageof 81

Showing results (571-580 of 804) with videos related to

Sort By:
Pageof 81
Transplantation and Cellular Therapy|April 4, 2023
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationJuliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, et al.
Blood Advances|October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysisMehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2025
Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving ChemoimmunotherapyP Connor Johnson, Jeremy S Abramson, Ann S LaCasce, et al.
American Journal of Hematology|May 21, 2024
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysisAseel Alsouqi, Gulrayz Ahmed, Juntian Wang, et al.
Blood Neoplasia|June 2, 2025
Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational studyPriyanka Pullarkat, Matthew Lei, Robert Redd, et al.
Haematologica|April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemiaMatthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Neurogastroenterology and Motility|May 11, 2026
A Clinical Practice Update for the Management of Patients With Disorders of Gut-Brain Interaction and Altered Food Intake BehaviorAyesha Shah, Nicholas J Talley, Simon R Knowles, et al.
Transplantation and Cellular Therapy|November 6, 2022
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid MalignanciesMatthew P Connor, Alison W Loren, Elizabeth O Hexner, et al.
Journal of Geriatric Oncology|June 17, 2023
Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemiaP Connor Johnson, Jennifer A Woyach, Angela Ulrich, et al.
Pageof 81